LeonaBio to Present ATH-1105 ALS Trial Strategy at ALS Drug Development Summit

LeonaBio

LeonaBio

LONA

0.00
  • LeonaBio will present at the 5th Annual ALS Drug Development Summit in Boston on June 2-4, 2026.
  • Chief Medical Officer Javier San Martin is scheduled to speak on June 3 at 2:50 p.m. ET.
  • LeonaBio will also participate in the BIO International Convention in San Diego on June 22-25, 2026.
  • Oncology consultant David Portman is scheduled to join a panel on June 24 at 11:00 a.m. PT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeonaBio Inc. published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.